The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinoma
- 10 November 2008
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 217 (3) , 345-352
- https://doi.org/10.1002/path.2487
Abstract
A micro‐array analysis using biopsies from patients with EBV‐positive undifferentiated nasopharyngeal carcinoma (NPC) and from cancer‐free controls revealed down‐regulation of tumour suppressor genes (TSG) not previously associated with this disease; one such gene was the ataxia telangiectasia mutated (ATM) gene. Q‐PCR confirmed down‐regulation of ATM mRNA and ATM protein expression in tumour cells was weak or absent in almost all cases. In NPC cell lines, however, ATM was down‐regulated only in the EBV‐positive line, C666.1, and in none of five EBV‐negative lines. In vitro infection of EBV‐negative NPC cell lines with a recombinant EBV was followed by the down‐regulation of ATM mRNA and protein, and only EBV‐positive cells showed a defective DNA damage response following γ‐irradiation. Our data suggest that loss of ATM function could be an important step in the pathogenesis of NPC, and may have implications for the treatment of this disease. Copyright © 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- Down‐regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivationThe Journal of Pathology, 2007
- Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cellsBlood, 2006
- Analysis of Epstein–Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assaysJournal of General Virology, 2006
- Epstein-Barr virus (EBV) and its associated human cancers - Genetics, epigenetics, pathobiology and novel therapeuticsFrontiers in Bioscience-Landmark, 2006
- The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanismsOral Oncology, 2005
- Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLLBlood, 2005
- Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agentsBiochemical Society Transactions, 2004
- Concurrent and Adjuvant Chemotherapy for Nasopharyngeal Carcinoma: A Factorial StudyJournal of Clinical Oncology, 2004
- Variations in ATM Protein Expression During Normal Lymphoid Differentiation and Among B-Cell-Derived NeoplasiasThe American Journal of Pathology, 2003
- Chk2 Activation Dependence on Nbs1 after DNA DamageMolecular and Cellular Biology, 2001